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Hepatitis C virus genome replication occurs in endoplasmic reticulum-derivedmembrane compartments, but
it is unknown how these structures arise. In this issue of Cell Host & Microbe, Reiss and colleagues (2011)
show that the virus recruits a specific lipid kinase to replication sites, stimulates its kinase activity, and alters
the phospholipid profile of replication compartments.All positive-strand RNA viruses replicate
their genomes in the cytoplasm of in-
fected cells with virally encoded enzymes
and host factors that associate with
cellular membranes. For hepatitis C virus
(HCV), a major cause of acute and chronic
hepatitis, RNA replication takes place in
an endoplasmic reticulum (ER)-derived
structure called the membranous web
(Moradpour et al., 2007). Based on the
resistance of isolated HCV replication
complexes to protease and nuclease
treatment (Quinkert et al., 2005) and their
partial sensitivity to detergents, replica-
tion is thought to take place within invag-
inations of a cholesterol- and sphingo-
myelin-rich membrane (Figure 1A).
While it is not yet known how the
membranous web forms, expression of
the viral nonstructural (NS) protein NS4B
can induce similar structures in uninfected
cells. Once a functional replication com-
plex forms, the viral genome is copied
by the NS5B RNA-dependent RNA poly-
merase (RdRP), which likely functions in
concert with the NS3-4A RNA helicase
and NS5A RNA-binding phosphoprotein.
In addition to viral NS proteins, host
factors that participate in HCV replication
have been identified through several
genome-wideand targetedsiRNAscreens
(for instance, see Berger et al., 2009;
Borawski et al., 2009; Li et al., 2009; Tai
et al., 2009; Vaillancourt et al., 2009). Due
to differences in experimental design
and analysis, few studies identified host
factors in common, and specific roles in
viral replication have not been determined
for most of these host factors. Neverthe-
less, one essential HCV host factor that
was reported across several studies is
phosphatidylinositol 4-kinase, subtype IIIa
(PI4KIIIa). This lipid kinase localizes to theER, Golgi complex, and plasma mem-
brane and is responsible for phosphory-
lating the 4 position of the inositol ring
in phosphatidylinositol (PI) to generate
PI4P. Other PI kinases phosphorylate PI
at the 2, 3, 4, and 5 positions, and the
action of multiple PI kinases can give
rise to mono-, bi- and triphosphorylated
species. Thus, the subcellular localization
of PI kinases and regulation of their
activity determine the profile of phosphati-
dylinositol phosphates (PIPs) found in
different cellular membranes. Because
many membrane trafficking proteins are
PIP-binding proteins that can discriminate
between different PIP species, PI kinases
(and PI phosphatases) play important
roles in determining the dynamic phos-
pholipid and protein composition of
cellular membranes.
In the present study, Reiss and
colleagues performed a genome-wide
siRNA screen to identify cellular kinases
that enhance or inhibit HCV replication.
The notable features of this screen were
that (1) it was comprehensive for all anno-
tated kinases within the human genome,
(2) it was performed with infectious virus,
and (3) extensive validation experiments
were performed. A total of 13 kinases
were identified that, when knocked
down, decreased HCV RNA replication.
Of these, PI4KIIIa had the strongest vali-
dation scores and was therefore pursued
further. The authors showed that PI4KIIIa
colocalized to sites of HCV RNA repli-
cation and was required in other cell
culture models of HCV RNA replication.
In contrast, knockdown of PI4KIIIb had
only minor inhibitory effects on a subset
of HCV isolates tested. Importantly, off-
target effects of the siRNA knockdown
experiments were excluded by showingCell Host & Microbethat HCV replication could be comple-
mented by expression of an siRNA-resis-
tant form of PI4KIIIa and that complemen-
tation depended on expression of a
catalytically active kinase.
To clarify the mechanism by which
PI4KIIIa contributes to viral replication,
the authors showed that PI4KIIIa knock-
down inhibited viral NS protein-induced
formation of the membranous web.
Instead, NS protein expression caused
a profusion of double-membrane vesi-
cles, which are often seen adjacent to
but distinct from the membranous web.
Thus, PI4KIIIa was necessary for proper
formation of the viral replication compart-
ment. The authors further showed that
PI4P accumulates in viral replication
compartments within infected cultured
cells and in HCV-positive regions of
liver biopsies from chronically infected
patients. Finally, the most insightful ex-
periment of this paper was the demon-
stration that the viral NS5A protein
binds PI4KIIIa and stimulates its kinase
activity. Taken together, these results
show that the interaction between NS5A
and PI4KIIIa plays an essential role in
forming the HCV replication complex,
most likely by generating PI4P.
A big unanswered question is ‘‘how
does PI4P contribute to HCV replica-
tion?’’ As stated above, the profile of
PIPs within a given membrane helps to
regulate the spectrum of cellular proteins
that associate with that membrane.
Thus, PI4P might be needed to recruit an
essential cellular effector protein (Fig-
ure 1B). As noted by Reiss and colleagues
in their Discussion, one likely candidate is
oxysterol binding protein (OSBP). OSBP
binds PI4P though a pleckstrin homology
domain and was previously shown to be9, January 20, 2011 ª2011 Elsevier Inc. 1
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Figure 1. PI4KIIIa Is Needed for HCV Replication Complex Assembly
(A and B) HCV RNA replication is thought to take place within invaginations of an ER-derived membrane. The viral NS3-4A, NS4B, NS5A, and NS5B proteins are
all essential for this process (A). NS5A binds and activates PI4KIIIa, leading to the local production of PI4P (B). One possibility is that PI4P then recruits viral or
cellular factors that are essential for forming the replication compartment.
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et al., 2009). OSBP is itself involved in lipid
metabolism, acting as a transporter of
cholesterol and oxidized cholesterol, and
could be directly involved in producing
the sterol-rich membranous web. Thus,
PI4KIIIa-generated PI4P could recruit
OSBP to form sites of RNA replication.
Clearly, more experiments are needed to
test this hypothesis and to determine
whether additional PI4P-binding proteins
are necessary for HCV replication.
In addition to cellular factors, PI4KIIIa-
generated PI4P could serve to mediate
the membrane association of viral pro-
teins. For instance, Hsu and colleagues
recently showed that enteroviruses,
a very distantly related group of positive-
strand RNA viruses that includes polio-
virus and coxsackievirus, recruit and
activate PI4KIIIb to sites of RNA replica-
tion (Hsu et al., 2010). Intriguingly, these
authors showed that the poliovirus
RdRP preferentially binds PI4P, sug-
gesting that PI4P is needed for replica-
tion complex assembly. While the HCV
RdRP, NS5B, associates with mem-
branes via a C-terminal tail anchor
(Moradpour et al., 2007), it is possible
that NS5B has an uncharacterized affinity
for PI4P that could reflect a deep
evolutionary relationship among posi-
tive-strand RNA viruses.2 Cell Host & Microbe 9, January 20, 2011 ª2Finally, it is interesting that NS5A is the
HCV factor that mediates interaction with
PI4KIIIa. Since NS5A can be phosphory-
lated on multiple serine residues, it would
be interesting to know whether NS5A
phosphorylation affects its ability to
recruit and activate PI4KIIIa. If so, this
could reflect a dynamic role for NS5A in
integrating and coordinating multiple
replication processes, including replica-
tion site assembly. Furthermore, a new
class of NS5A-binding compounds has
recently proven to be extremely potent
at inhibiting HCV replication, with a half-
maximal effectiveness in the picomolar
range (Gao et al., 2010). While the molec-
ular basis of their inhibition remains
unclear, it is tempting to speculate that
they could inhibit NS5A’s ability to recruit
PI4KIIIa and initiate replication complex
assembly.
Despite years of study, we have only
just begun to scratch the surface in under-
standing how positive-stand RNA viruses
manipulate membrane biology. With this
publication, Reiss and colleagues have
made a major stride forward, and the field
welcomes these insights.REFERENCES
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